Søgeresultater - Simone de Haij
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden af Péter Boross, J.H. Marco Jansen, Simone de Haij, Frank J. Beurskens, Cees E. van der Poel, Lisette Bevaart, Maaike Nederend, Josée Golay, Jan G. J. van de Winkel, Paul W.H.I. Parren, Jeanette H.W. Leusen
Udgivet 2011Artigo -
5
<i>In vivo</i> Cytotoxicity of Type I CD20 Antibodies Critically Depends on Fc Receptor ITAM Signaling af Simone de Haij, J.H. Marco Jansen, Péter Boross, Frank J. Beurskens, Jantine E. Bakema, Desirée L. Bos, Anton C. Martens, J. Sjef Verbeek, Paul W.H.I. Parren, Jan G. J. van de Winkel, Jeanette H.W. Leusen
Udgivet 2010Artigo -
6
A Spectrum of Mutations in the Second Gene for Autosomal Dominant Polycystic Kidney Disease (PKD2) af Barbera Veldhuisen, Jasper J. Saris, Simone de Haij, Tomohito Hayashi, David M. Reynolds, Toshio Mochizuki, R Elles, Ragnheiður Fossdal, Nadja Bogdanova, Marjan A. van Dijk, Eliécer Coto, David Ravine, Søren Nørby, C. Verellen‐Dumoulin, M.H. Breuning, Stefan Somlo, Dorien J.M. Peters
Udgivet 1997Artigo -
7
Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy af Joeri A. Jansweijer, Karin Nieuwhof, Francesco Paolo Russo, Edgar T. Hoorntje, Jan D.H. Jongbloed, Ronald H. Lekanne Deprez, Alex V. Postma, Marieke Bronk, Ingrid A.W. van Rijsingen, Simone de Haij, Elena Biagini, Paul L. van Haelst, Jan van Wijngaarden, Maarten P. van den Berg, Arthur A.M. Wilde, Marcel M.A.M. Mannens, Rudolf A. de Boer, Karin Y. van Spaendonck‐Zwarts, J. Peter van Tintelen, Yigal M. Pinto
Udgivet 2016Artigo
Søgeredskaber:
Relaterede emner
Biology
Genetics
Immunology
Biochemistry
Gene
In vitro
Medicine
Mutation
Antibody
Cancer research
Cardiology
Cell biology
Chemistry
Immune system
In vivo
Inflammation
Internal medicine
Molecular biology
Monoclonal antibody
Physics
Action (physics)
Antibody-dependent cell-mediated cytotoxicity
Astronomy
Autosomal dominant polycystic kidney disease
Biotechnology
C-reactive protein
CD20
CD40
Cardiomyopathy
Chemokine